ARCHIVE

• Sumitomo Pharm.: Sales Up 4.0% to \142,347 Mil.
  May 23, 2005

• GL to Assess Equivalency of Biological Products Announced
  May 23, 2005

• Asahi Kasei Pharma: Sales Fall 1.9% to \103,930 Mil.
  May 23, 2005

• REGULATORY NEWS IN BRIEF
  May 23, 2005

• Nippon Shinyaku: Major Products Prop Up Sales
  May 23, 2005

• Daiichi Sankyo Aims at \932 Bil. in FY2009
  May 23, 2005

• Tsumura: Drug Sales Up 4.1% to \70,805 Mil.
  May 23, 2005

• BUSINESS NEWS IN BRIEF
  May 23, 2005

• Toyama Chemical: Sales Up 47.0% to \24,746 Mil.
  May 23, 2005

• Takeda: Consolidated Sales Top \1,100 Bil.
  May 23, 2005

• Kyowa Hakko to Build "Base for Future Growth" Over Next 3 Years
  May 23, 2005

• Overseas Sales Drive Eiken's Business
  May 23, 2005

• JAMS, JACCC to Reconcile Cancer Specialist Systems of JSCO and JSMO
  May 23, 2005

• NEW PRODUCTS
  May 23, 2005

• Sankyo: Mevalotin Patent Expiration Hits Business
  May 23, 2005

• R&D NEWS IN BRIEF
  May 23, 2005

• MPC Aims at Becoming Global Pharma through Holding Company
  May 23, 2005

• Spiriva Can Cut COPD Treatment Cost by ¥59 Bil. a Year
  May 23, 2005

• Discovering 2 to 3 New Drug Candidates a Year "Achievable": Tanabe Seiyaku
  May 23, 2005

• PMDA to Restart Receiving Applications for Clinical Trial Consultation
  May 23, 2005

ページ

• « 先頭
• ‹ Prev
• …
• 465
• 466
• 467
• 468
• 469
• 470
• 471
• 472
• 473
• …
• Next ›
• 最終 »